斜坡序列可能解释同义变体与阿尔茨海默病的相关性在配对免疫球蛋白类型2受体α (PILRA) 中
Justin B Miller1,2,3,4, J Anthony Brandon2, Lauren M Harmon5
1Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY 40506, USA.
Biomedicines
|March 28, 2025
概括
皮拉基因中的rs2405442:T>C变体显著降低了mRNA和蛋白质水平. 这一发现表明,编码突变序列可能调节与阿尔茨海默病相关的基因.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 一种同名变异,rs2405442:T>C,在配对免疫球蛋白类型2受体α (PILRA) 基因中与阿尔茨海默病 (AD) 的风险降低有关.
- 这种关联背后的精确生物机制在很大程度上仍未被阐明.
研究的目的:
- 为了研究 rs2405442:T>C 变异减少 PILRA mRNA 和蛋白质表达的假设.
- 探索编码突起序列在调节与AD相关的基因表达中的作用.
主要方法:
- 使用定量聚合酶链反应 (qPCR) 来评估mRNA水平.
- 与酶相关的免疫吸收试验 (ELISA) 用于测量蛋白质水平.
- 实验中使用中国仓鼠卵巢 (CHO) 细胞来评估变体的影响.
主要成果:
- 与野生型相比,rs2405442:T>C变异导致PILRA mRNA水平 (p = 1.9184 × 10−13) 和蛋白质水平 (p = 0.01296) 在统计学上显著下降.
- 这些观察到的下降与该变体在PILRA的5'末端的干道序列上的预测影响一致.
结论:
- 这项研究表明rs2405442:T>C变异直接影响PILRA mRNA和蛋白质表达.
- 这些发现表明,编码突变序列可能是阿尔茨海默病相关基因的调节机制,独立于蛋白质产品的修饰.
相关概念视频
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


